Ultomiris Drug Market: In-Depth Overview, Growth Drivers, Segmentation, and Future Outlook The Ultomiris Drug Market is experiencing robust growth as demand for advanced biologic therapies continues to rise globally. Ultomiris (ravulizumab), developed by AstraZeneca through Alexion Pharmaceuticals, is a long-acting monoclonal antibody designed to treat rare, life-threatening...